These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30219991)

  • 1. Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.
    Kim MH; Xu L; Puckrein G
    Adv Ther; 2018 Nov; 35(11):2069-2080. PubMed ID: 30219991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Warfarin on Atrial-Fibrillation Outcomes Related to Economic Consumption Patterns: Hospitalization, Cost, and Mortality may be Predictable and Modifiable at the Population Level.
    Kim MH; Cai Q; Xu L; Puckrein GA
    Adv Ther; 2016 Sep; 33(9):1579-99. PubMed ID: 27457471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
    Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.
    Shroff GR; Solid CA; Herzog CA
    J Am Heart Assoc; 2014 Jun; 3(3):e000756. PubMed ID: 24895161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
    Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
    Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Meschia JF; Merrill P; Soliman EZ; Howard VJ; Barrett KM; Zakai NA; Kleindorfer D; Safford M; Howard G
    Stroke; 2010 Apr; 41(4):581-7. PubMed ID: 20190000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
    Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
    Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
    Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
    Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
    JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnicity and stroke risk in patients with atrial fibrillation.
    Mathur R; Pollara E; Hull S; Schofield P; Ashworth M; Robson J
    Heart; 2013 Aug; 99(15):1087-92. PubMed ID: 23720487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.
    Turakhia MP; Hoang DD; Xu X; Frayne S; Schmitt S; Yang F; Phibbs CS; Than CT; Wang PJ; Heidenreich PA
    Am Heart J; 2013 Jan; 165(1):93-101.e1. PubMed ID: 23237139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries.
    Raji MA; Lowery M; Lin YL; Kuo YF; Baillargeon J; Goodwin JS
    Ann Pharmacother; 2013 Jan; 47(1):35-42. PubMed ID: 23324508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).
    Lakshminarayan K; Solid CA; Collins AJ; Anderson DC; Herzog CA
    Stroke; 2006 Aug; 37(8):1969-74. PubMed ID: 16809573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
    Perino AC; Shrader P; Turakhia MP; Ansell JE; Gersh BJ; Fonarow GC; Go AS; Kaiser DW; Hylek EM; Kowey PR; Singer DE; Thomas L; Steinberg BA; Peterson ED; Piccini JP; Mahaffey KW
    J Am Heart Assoc; 2019 May; 8(9):e011205. PubMed ID: 31023126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
    Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
    CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: effect of diabetes.
    Shroff GR; Solid CA; Bloomgarden Z; Halperin JL; Herzog CA
    J Diabetes; 2017 Feb; 9(2):115-122. PubMed ID: 26929264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.